Advertisement

Topics

Summit Therapeutics to Report First Quarter 2015 Financial Results on 11 June 2015

20:00 EDT 4 Jun 2015 | Globe Newswire

OXFORD, United Kingdom, June 5, 2015 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (Nasdaq:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and C. difficile infection, will be reporting its first quarter financial results for the period ending 30 April 2015 on Thursday, 11 June 2015.

About Summit Therapeutics

Summit is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies. Summit is conducting clinical programs focused on the genetic disease Duchenne muscular dystrophy and the infectious disease C. difficile infection. Further information is available at www.summitplc.com and Summit can be followed on Twitter (@summitplc).

For more information, please contact:

Summit Therapeutics
Glyn Edwards / Richard Pye (UK office)
Erik Ostrowski (US office)
 
 Tel: +44 (0)1235 443 951
         +1 617 294 6607
 
Cairn Financial Advisers LLP
(Nominated Adviser)
Liam Murray / Tony Rawlinson
 
 
 Tel: +44 (0)20 7148 7900
 
N+1 Singer
(Broker)
Aubrey Powell / Jen Boorer 
 
 
 Tel: +44 (0)20 7496 3000
 
MacDougall Biomedical Communications
(US media contact)
Michelle Avery
 
Tel: +1 781 235 3060
mavery@macbiocom.com
 
Peckwater PR
(Financial public relations, UK)
Tarquin Edwards

Tel: +44 (0)7879 458 364
tarquin.edwards@peckwaterpr.co.uk
NEXT ARTICLE

More From BioPortfolio on "Summit Therapeutics to Report First Quarter 2015 Financial Results on 11 June 2015"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Muscular Dystrophy
Muscular dystrophy is a group of degenerative inherited disorders causing muscle weakness and loss of muscle tissue. The different types are Becker muscular dystrophy, Duchenne muscular dystrophy, Emery-Dreifuss muscular dystrophy, Facioscapulohumeral mu...

Clostridium difficile (CDI)
A clostridium difficile infection (CDI) is a type of bacterial infection that can affect the digestive system. It most commonly affects people who are staying in hospital.  The symptoms of CDI can range from mild to severe and include: diarrhoe...